The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Details of a clinical trial for PR positive advanced/recurrent endometrial andnorcarcinoma and low g

Felixthecat
Felixthecat CSN Member Posts: 37
edited March 2014 in Gynecological Cancers (other than ovarian and uterine) #1
Ladies,
Details of a clinical trial for PR positive advanced/recurrent endometrial andnorcarcinoma and low grade endometrial stromal sarcoma - get the details via the link copied below if you qualify:


Mifepristone for Patients With Endometrial Cancer and LGESS
This study is currently recruiting participants.
Verified by M.D. Anderson Cancer Center, July 2007
http://clinicaltrials.gov/ct2/show/NCT00505739?cond="Carcinoma,+Endometrioid"&rank=3

Phase II Study of Mifepristone (RU-486) in the Treatment of PR Positive Advanced/Recurrent Endometrioid Adenocarcinoma and Low Grade Endometrial Stromal Sarcoma (LGESS)
Like Care

Discussion Boards